3394 Alpha-1-acid glycoprotein as outcome, independent predictor, and effect modifier in a randomized, placebo-controlled, factorial trial of recombinant human growth hormone and rosiglitazone in people living with HIV

OBJECTIVES/SPECIFIC AIMS: In a randomized controlled trial in participants with HIV infection, recombinant human growth hormone (rhGH) reduced visceral adipose tissue (VAT); addition of rosiglitazone to rhGH prevented the accompanying decline in insulin sensitivity (SI). Within this parent RCT, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gannon, Bryan M., Glesby, Marshall J., Mehta, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Clinical Epidemiology/Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799660/
http://dx.doi.org/10.1017/cts.2019.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799660/
http://dx.doi.org/10.1017/cts.2019.80

Ejemplares similares